PHN Share Price Performance
€48.05
-6.35 (-11.67%)
Price €48.05
Share Price€48.05
Pharmanutra's (BIT:PHN) Dividend Will Be Increased To €1.00
Mar 20
Pharmanutra S.p.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
PHN Community Narratives
There are no narratives available yet.
Pharmanutra S.p.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.76
- Gross Margin
- 52.75%
- Net Profit Margin
- 13.82%
- Debt/Equity Ratio
- 36.1%
Pharmanutra S.p.A. Competitors
Snowflake Analysis
About PHN
- Founded
- 2003
- Employees
- 118
- CEO
- WebsiteView website
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Italian Market Performance
- 7 Days: 1.7%
- 3 Months: 7.6%
- 1 Year: 26.7%
- Year to Date: 23.5%
The market has climbed 1.8% in the last 7 days, lead by the Consumer Discretionary sector with a gain of 6.2%. In the last year, the market has climbed 27%. As for the next few years, earnings are expected to grow by 9.7% per annum. Market details ›